High-altitude Physiology: Lessons from Tibet

Peter D. Wagner,Tatum S. Simonson,Guan Wei,Harrieth Wagner,Tanna Wuren,Ma Yan,Ga Qin,Rili Ge
DOI: https://doi.org/10.1117/12.2020038
2013-01-01
Abstract:Polycythemia is a universal lowlander response to altitude; healthy Andean high-altitude natives also have elevated [Hb]. While this may enhance O-2 transport to tissues, studies have shown that acute isovolumic changes in [Hb] do not affect exercise capacity. Many high-altitude Tibetans have evolved sea-level values of [Hb], providing a natural opportunity to study this issue. In 21 young healthy male Tibetans with [Hb] between 15 and 23 g/dl, we measured (V) over dotO(2)MAX and O-2 transport capacity at 4200m. (V) over dotO(2)MAX was higher when [Hb] was lower (P<0.05), enabled by both higher cardiac output and muscle O-2 diffusional conductance, but neither ventilation nor the alveolar-arterial PO2 difference (AaPO(2)) varied with [Hb]. In contrast, Andean high altitude natives remain polycythemic with larger lungs and higher lung diffusing capacity, a smaller exercising AaPO(2), and lower ventilation. The challenges now are (1) to understand the different adaptive pathways used by Andeans and Tibetans, and (2) to determine in Tibetans whether, during evolution, reduced [Hb] appeared first, causing compensatory cardiac and muscle adaptations, or if enhanced cardiac function and muscle O-2 transport capacity appeared first, permitting secondary reduction in [Hb]. For (2), further research is necessary to determine the basis of enhanced cardiac function and muscle O-2 transport, and identify molecular targets of evolution in heart and muscle. Putative mutations can then be timed and compared to appearance of those affecting [Hb].
What problem does this paper attempt to address?